Do you record the lot and expiration of any or all of the following products in your EHR system (either by nursing during administration or by pharmacy at order entry/verification)?
-prolastin
-IVIG
-Kcentra
-Rhogam
-prolastin
-Rabies immune globulin

I noted the FDA has recently updated the "Warnings and Precautions" section of the drug labeling for several paralytics to include a new subsection "Risk of Death Due to Medication Errors".

I don't recall seeing this subsection for other medications but perhaps I am mistaken. Has anyone noticed this subsection added to other agents?

Has anyone been able to compare their inpatient narcan usage with other sites or have you found a benchmark by chance?
Thank you in advance!

Hello -

Recognizing that 'medication error rates' captured by voluntary incident reports is the least effective and least reliable determinant of true error rates / benchmarking....

I wondered if other institutions have developed executive-level (or really any level) benchmarks / dashboards / metrics which they follow in their health system to track performance improvement within medication safety and safety realms?

I would be particularly interested if anyone has develop these measures in the outpatient / ambulatory spaces as well.

Hey safety gurus!

Wanted to know if anyone has any input/guidance regarding having a default age/DOB for the pediatric unknown patient (e.g., trauma patient) in order to get the patient registered and allow orders to be entered. EPIC is our EMR and most things (alerts, normal ranges, etc) are based on age and weight. We are trying to find a way to choose a default age/DOB that allows us to get the patient registered and orders entered, while maintaining our medication and lab safeguards.

Thanks in advance for any help that you can provide.

-Jameika

How do you dispense remifentanil for use by anesthesia?
Do you draw up syringes for them?
Dispense vials and they draw up?
Purchase premade syringes for their use?

Thank you,
Ann

Our opioid stewardship team is trying to determine the best way to meet the Joint Commission Pain Management Standard for identifying high risk patient's. We would like to flag patient's who are considered high risk for opioid related harm via Epic. Has anyone successfully implemented this at your institution. How are you meeting this standard and identifying high risk patients?

In the ED Zofran is often given quickly and early (from or in triage). Do you have any systems in place to ensure that patients with congenital prolonged QTc do not get it? We are seeing that those that prescribe it in the ED are usually NP's and residents that may not realize the connection yet.

Therefore looking to see what, if any, measures you have in place to prevent it's prescribing.

Hello.

I'm wondering what occurs at your organization when a vascular access device infiltrates/extravasates. If the agent that infiltrated/extravasated has an antidote, do you always use it or is it based on severity of the event?

I appreciate your guidance,
Stacie Ethington
Nebraska Medicine

HI All,
I really enjoyed the "Great Safety Debate" at the ASHP Annual meeting. As part of the follow up to the drug testing debate, I have begun to look at what pharmacies or hospitals have done for fatigue management/ alertness in a structured way. I had a recent discussion with a vendor that was mentioned at the debate and I think my coworkers were a bit surprised how pharmacies are staffed in the real world with call ins, doubles, 7 on 7 off midnights, etc. (often in violation of fatigue management principles).